Trevi Therapeutics Inc (TRVI) Insider Trading
- $10,715,499.40
- $1,976,506.14
- Sept. 9, 2024
- Lisa Delfini
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Sept. 9, 2024 | CEO | 1,840 | $3.04 | Sell | $5,593.60 | |
| Sept. 6, 2024 | CEO | 4,219 | $3.03 | Sell | $12,783.57 | |
| Sept. 4, 2024 | CEO | 10,981 | $3.02 | Sell | $33,162.62 | |
| Aug. 27, 2024 | Director | 4,555 | $2.93 | Sell | $13,346.15 | |
| Aug. 16, 2024 | Insider | 18,660 | $2.76 | Sell | $51,501.60 | |
| Aug. 14, 2024 | Insider | 100 | $2.75 | Sell | $275.00 | |
| May 29, 2024 | Insider | 53,368 | $2.55 | Sell | $136,088.40 | |
| May 22, 2024 | CFO | 4,350 | $2.64 | Sell | $11,484.00 | |
| May 20, 2024 | CEO | 25,037 | $2.86 | Sell | $71,605.82 | |
| May 10, 2024 | CEO | 4,578 | $2.90 | Sell | $13,276.20 | |
| Oct. 11, 2023 | CFO | 785 | $2.02 | Sell | $1,585.70 | |
| Sept. 11, 2023 | CFO | 711 | $2.20 | Sell | $1,564.20 | |
| Aug. 11, 2023 | CFO | 682 | $2.36 | Sell | $1,609.52 | |
| July 11, 2023 | CFO | 687 | $2.34 | Sell | $1,607.58 | |
| June 12, 2023 | CFO | 610 | $2.64 | Sell | $1,610.40 | |
| April 11, 2023 | CFO | 840 | $1.84 | Sell | $1,545.60 | |
| March 13, 2023 | CFO | 892 | $1.75 | Sell | $1,561.00 | |
| Feb. 13, 2023 | CFO | 8,474 | $2.45 | Sell | $20,761.30 | |
| July 5, 2022 | Major Shareholder | 63,569 | $3.11 | Sell | $197,699.59 | |
| July 1, 2022 | Major Shareholder | 436,431 | $2.86 | Sell | $1,248,192.66 | |
| June 29, 2022 | Major Shareholder | 46,128 | $2.74 | Sell | $126,390.72 | |
| May 2, 2022 | Major Shareholder | 600 | $2.70 | Sell | $1,620.00 | |
| April 28, 2022 | Major Shareholder | 7,271 | $2.77 | Sell | $20,140.67 | |
| April 11, 2022 | Major Shareholder | 3,580,526 | $1.90 | Buy | $6,802,999.40 | |
| April 3, 2020 | Major Shareholder | 564 | $2.66 | Sell | $1,500.24 | |
| May 9, 2019 | Major Shareholder | 375,000 | $10.00 | Buy | $3,750,000.00 | |
| May 9, 2019 | Director | 5,000 | $10.00 | Buy | $50,000.00 | |
| May 9, 2019 | Insider | 11,250 | $10.00 | Buy | $112,500.00 |
Insiders are both buying and selling Trevi Therapeutics Inc stock.
The insider traders at Trevi Therapeutics Inc are: Lisa Delfini, Jennifer L Good, Tpg Gp A, Llc, Thomas Sciascia, Invest A/S Lundbeckfond, Enterprise Associates 16 New, David P Meeker, Paul Edward Walker, and Anne Vanlent
The most active insider trader at Trevi Therapeutics Inc is Lisa Delfini with 9 trades.
Tpg Gp A, Llc has sold the most Trevi Therapeutics Inc stock with a total value of $1,791,743.23.
Paul Edward Walker has bought the most Trevi Therapeutics Inc stock with a total value of $13,605,998.80.
The most recent insider trade for Trevi Therapeutics Inc was on Sept. 9, 2024.
The single biggest insider buy for Trevi Therapeutics Inc was from Paul Edward Walker with a total value of $6,802,999.40 on April 11, 2022.
The single biggest insider sell for Trevi Therapeutics Inc was from Tpg Gp A, Llc with a total value of $1,248,192.66 on July 1, 2022.